Principal Investigator and Director
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Targeted Protein Degrader Therapeutics: Opportunities and Challenges (S16)
Wednesday, November 20, 2024
9:00 AM - 12:00 PM CT
Understanding Safety Liabilities of Small Molecule Targeted Protein Degraders (S16-2)
Wednesday, November 20, 2024
9:05 AM - 9:25 AM CT